Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
Journal of Applied Toxicology · 2024
DOI: 10.1002/jat.4617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2024. Verfasst von Yitong Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Toxicology, Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administra…. Hauptthemen laut MEDLINE: Computer Simulation, Quantitative Structure-Activity Relationship, Models, Biological. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Botanicals contain complex mixtures of chemicals most of which lack pharmacokinetic data in humans. Since physicochemical and pharmacokinetic properties dictate the in vivo exposure of botanical constituents, these parameters greatly impact the pharmacological and toxicological effects of botanicals in consumer products. This study sought to use computational (i.e., in silico) models, including quantitative structure–activity relationships (QSAR) and physiologically based pharmacokinetic (PBPK) modeling, to predict properties of botanical constituents. One hundred and three major constituents (e.g., withanolides, mitragynine, and yohimbine) in 13 botanicals (e.g., ashwagandha, kratom, and yohimbe) were investigated. The predicted properties included biopharmaceutical classification system (BCS) classes based on aqueous solubility and permeability, oral absorption, liver microsomal clearance, oral bioavailability, and others. Over half of these constituents fell into BCS classes I and II at dose levels no greater than 100 mg per day, indicating high permeability and absorption (%F a > 75%) in the gastrointestinal tract. However, some constituents such as glycosides in ashwagandha and Asian ginseng showed low bioavailability after oral administration due to poor absorption (BCS classes III and IV, %F a < 40%). These in silico results fill data gaps for botanical constituents and could guide future safety studies. For example, the predicted human plasma concentrations may help select concentrations for in vitro toxicity testing. Additionally, the in silico data could be used in tiered or batteries of assays to assess the safety of botanical products. For example, highly absorbed botanical constituents indicate potential high exposure in the body, which could lead to toxic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Toxicology, Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, Maryland, USA.
- Simulations Plus, Lancaster, California, USA.
- Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA.
- Health and Environmental Sciences Institute, Washington, DC, USA.
ORCID-Profile: Yitong Liu
Förderung
- Intramural NIH HHS
Zitieren
APA
Liu, Y., Lawless, M., Li, M., Fairman, K., Embry, M. R., & Mitchell, C. A. (2024). Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4617
Vancouver
Liu Y, Lawless M, Li M, Fairman K, Embry MR, Mitchell CA. Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models. Journal of Applied Toxicology. 2024. doi:10.1002/jat.4617
BibTeX
@article{Liu2024,
author = {Liu, Yitong and Lawless, Michael and Li, Miao and Fairman, Kiara and Embry, Michelle R and Mitchell, Constance A},
title = {Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models},
journal = {Journal of Applied Toxicology},
year = {2024},
doi = {10.1002/jat.4617}
}
EUVIMED